Chinese firm makes last-minute $1.4 billion offer for Australia's Sirtex, trumps Varian: Reuters

Chinese private equity firm CDH Investments lobbed a last-minute $1.4 billion offer for Australian liver-cancer treatment firm Sirtex Medical (SRX.AX), trumping Varian Medical Systems (VAR.N) days before the U.S. firm was set to seal a takeover deal, Reuters reported.